Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir Fix Dose combination_The HepNet Acute HCV-V Study

NCT03818308 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT03818308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03818308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir Fix Dose combination_The HepNet Acute HCV-V Study
Lead sponsor
Hannover Medical School
Phase
Phase 2
Overall status
Completed
Start date
May 28, 2019
Completion date
June 8, 2021
Enrollment
20 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute hepatitis c, hepatitis c